- Home
- PCVX vs CHE Comparison
PCVX vs CHE Comparison
Compare PCVX & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- CHE
- Stock Information
- Founded
- PCVX 2013
- CHE 1970
- Country
- PCVX United States
- CHE United States
- Employees
- PCVX N/A
- CHE N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- CHE Medical/Nursing Services
- Sector
- PCVX Health Care
- CHE Health Care
- Exchange
- PCVX Nasdaq
- CHE Nasdaq
- Market Cap
- PCVX 8.8B
- CHE 8.7B
- IPO Year
- PCVX 2020
- CHE N/A
- Fundamental
- Price
- PCVX $111.58
- CHE $572.59
- Analyst Decision
- PCVX Strong Buy
- CHE Buy
- Analyst Count
- PCVX 7
- CHE 2
- Target Price
- PCVX $139.17
- CHE $673.50
- AVG Volume (30 Days)
- PCVX 1.2M
- CHE 61.9K
- Earning Date
- PCVX 11-04-2024
- CHE 10-23-2024
- Dividend Yield
- PCVX N/A
- CHE 0.35%
- EPS Growth
- PCVX N/A
- CHE 31.50
- EPS
- PCVX N/A
- CHE 19.72
- Revenue
- PCVX N/A
- CHE $2,335,557,000.00
- Revenue This Year
- PCVX N/A
- CHE $8.90
- Revenue Next Year
- PCVX N/A
- CHE $7.70
- P/E Ratio
- PCVX N/A
- CHE $28.98
- Revenue Growth
- PCVX N/A
- CHE 6.79
- 52 Week Low
- PCVX $44.20
- CHE $492.84
- 52 Week High
- PCVX $119.27
- CHE $654.62
- Technical
- Relative Strength Index (RSI)
- PCVX 83.72
- CHE 50.04
- Support Level
- PCVX $77.21
- CHE $570.31
- Resistance Level
- PCVX $119.27
- CHE $590.00
- Average True Range (ATR)
- PCVX 3.55
- CHE 8.34
- MACD
- PCVX 3.97
- CHE -0.88
- Stochastic Oscillator
- PCVX 81.72
- CHE 24.94
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About CHE Chemed Corp
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.